These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Autoantibodies in thymoma-associated myasthenia gravis and their clinical significance]. Suzuki S Brain Nerve; 2011 Jul; 63(7):705-12. PubMed ID: 21747140 [TBL] [Abstract][Full Text] [Related]
6. Clinical and immunological predictors of prognosis for Japanese patients with thymoma-associated myasthenia gravis. Suzuki S; Nishimoto T; Kohno M; Utsugisawa K; Nagane Y; Kuwana M; Suzuki N J Neuroimmunol; 2013 May; 258(1-2):61-6. PubMed ID: 23561592 [TBL] [Abstract][Full Text] [Related]
7. Autoimmune targets of heart and skeletal muscles in myasthenia gravis. Suzuki S; Utsugisawa K; Yoshikawa H; Motomura M; Matsubara S; Yokoyama K; Nagane Y; Maruta T; Satoh T; Sato H; Kuwana M; Suzuki N Arch Neurol; 2009 Nov; 66(11):1334-8. PubMed ID: 19752287 [TBL] [Abstract][Full Text] [Related]
11. [New clinical entity of myasthenia gravis with autoimmune targets of heart and skeletal muscles]. Suzuki S Rinsho Shinkeigaku; 2012; 52(11):1312-4. PubMed ID: 23196602 [TBL] [Abstract][Full Text] [Related]
12. Anti-Kv1.4 Antibody Without Myasthenia Gravis: A Rare Cause of Autoimmune Myocarditis and Myositis. Kuyama N; Takashio S; Nagakura T; Imamura M; Takamatsu K; Takae M; Hirakawa K; Yamanaga K; Hanatani S; Yamamoto E; Matsushita K; Ueda M; Tsujita K JACC Case Rep; 2023 Mar; 9():101734. PubMed ID: 36909266 [TBL] [Abstract][Full Text] [Related]
13. Factors associated with response to calcineurin inhibitors in myasthenia gravis. Nagane Y; Suzuki S; Suzuki N; Utsugisawa K Muscle Nerve; 2010 Feb; 41(2):212-8. PubMed ID: 19816912 [TBL] [Abstract][Full Text] [Related]
14. [Determination and clinical significance of serum anti-ryanodine receptor antibody in patients with myasthenia gravis]. Cui LY; Li YF; Li YH; Zhang JB Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Apr; 29(2):238-40. PubMed ID: 17536276 [TBL] [Abstract][Full Text] [Related]
15. Neutralizing antibodies against endogenous interferon in myasthenia gravis patients. Bagnato F; Clemenzi A; Scagnolari C; Strizzi L; Di Pasquale A; Bellomi F; Di Marco P; Antonelli G; Antonini G Eur Cytokine Netw; 2004; 15(1):24-9. PubMed ID: 15217749 [TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis. Zhang B; Tzartos JS; Belimezi M; Ragheb S; Bealmear B; Lewis RA; Xiong WC; Lisak RP; Tzartos SJ; Mei L Arch Neurol; 2012 Apr; 69(4):445-51. PubMed ID: 22158716 [TBL] [Abstract][Full Text] [Related]
17. Remarkably increased resistin levels in anti-AChR antibody-positive myasthenia gravis. Zhang DQ; Wang R; Li T; Li X; Qi Y; Wang J; Yang L J Neuroimmunol; 2015 Jun; 283():7-10. PubMed ID: 26004149 [TBL] [Abstract][Full Text] [Related]
18. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice. Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395 [TBL] [Abstract][Full Text] [Related]
19. [Giant-cell myocarditis without a symptom of heart failure seen in a patient with myasthenia gravis and concurrent Hashimoto's disease]. Kanzato N; Nakasone I; Sunagawa O; Komine Y; Fukiyama K Rinsho Shinkeigaku; 2001 Nov; 41(11):813-7. PubMed ID: 12080616 [TBL] [Abstract][Full Text] [Related]
20. Study of anti-striational and anti-thyroid antibodies in patients with myasthenia gravis. Cojocaru IM; Cojocaru M; Muşuroi C Rom J Intern Med; 2000-2001; 38-39():111-20. PubMed ID: 15529579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]